Biomarker model predicts breast cancer risk without racial bias
CHICAGO -- A new breast cancer risk assessment technique that uses mammography biomarkers shows no racial bias, according to research presented November 29 at the RSNA meeting.The findings offer another way to foster breast cancer early detection, improve patient survival rates across different populations, and reduce disparity in survival rates, said study lead author Leslie Lamb, MD, of Massachusetts General Hospital (MGH) in Boston in a statement. “In the domain of precision medicine, risk-based screening has been elusive because we have not been able to accurately evaluate a woman’s risk of developing breast cance...
Source: AuntMinnie.com Headlines - November 29, 2023 Category: Radiology Authors: Liz Carey Tags: Subspecialties Womens Imaging Breast Imaging RSNA 2023 Source Type: news
ASTRO proposes new guidelines for aggressive breast cancer and DCIS
The American Society for Radiation Oncology (ASTRO) has released a proposed update to clinical practice guidelines for partial breast radiation as an alternative to whole breast radiation for early-stage invasive breast cancer and ductal carcinoma in situ (DCIS).
ASTRO’s recommendations are based on evidence from major clinical trials, said Janice Lyons, MD, chair of the guideline task force at the University Hospitals Seidman Cancer Center in Cleveland, OH, in a statement released by the society. The new guidance also addresses aspects related to the technical delivery of partial breast irradiation (PBI), including do...
Source: AuntMinnie.com Headlines - November 17, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Radiation Oncology Source Type: news
ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer
(MedPage Today) -- The American Society for Radiation Oncology (ASTRO) updated their guidelines on partial breast irradiation (PBI) for patients with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS).
These new guidelines take... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 16, 2023 Category: Hematology Source Type: news
Mammography-based nomogram predicts breast microcalcifications
A mammography-based radiomic nomogram could be useful in predicting risk of malignancy in suspicious breast microcalcifications, according to research published November 7 in Academic Radiology.
A team led by Yusi Chen from the Second Affiliated Hospital of Harbin Medical University in China found that the nomogram, which combined radiomic scoring with clinical factors, achieved a high area under the curve (AUC) value in a validation set of patients with breast microcalcifications.
“The combined model could be considered as a potential imaging marker to predict malignant risk,” Chen and colleagues wrote.
Differentia...
Source: AuntMinnie.com Headlines - November 8, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Advanced Visualization Breast Imaging Source Type: news
PET predicts chemotherapy responses in breast cancer patients
PET/CT with gallium-68 (Ga-68) FAPI radiotracer can predict responses to neoadjuvant chemotherapy in breast cancer patients, according to a study published November 2 in the Journal of Nuclear Medicine. A team in Fuzhou, China, found that Ga-68 FAPI uptake on early PET/CT scans during chemotherapy indicated which patients were most likely to experience complete responses. This information can have a major impact on how patients are guided through treatment, according to the authors.“Ga-68 FAPI-PET/CT parameters can rapidly provide feedback on tumor changes after only two cycles of chemotherapy,” wrote first author Ling...
Source: AuntMinnie.com Headlines - November 8, 2023 Category: Radiology Authors: Will Morton Tags: Clinical News Subspecialties Molecular Imaging Nuclear Medicine Breast Imaging Source Type: news
Beyond BRCA1/2: Pinpointing the risk of inherited breast cancer genes
Immunohistochemistry for HER2 shows positive membrane staining in this infiltrating ductal carcinoma. At the molecular level, breast cancer is typically broken down into four major subtypes — triple-negative, HER2-positive, luminal A and luminal B — each with different degrees of aggressiveness and responses to treatment. Risk can be a complicated and confounding concept, particularly when it comes to life-or-death situations like cancer. The discovery of the BRCA1 and BRCA2 genes in the 1990s enabled many… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 28, 2023 Category: Databases & Libraries Source Type: news
Histologic Analysis and Diagnostic Yield of Breast SCNB Histologic Analysis and Diagnostic Yield of Breast SCNB
This study evaluated the current detection rate of breast calcifications and DCIS using SCNB.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 8, 2023 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Ductal Carcinoma in Situ (DCIS): What It Is, Causes, Symptoms & Treatment
A breast cancer diagnosis can be terrifying, but one type of early-stage disease is noninvasive and has high survival odds.
There have been an estimated 297,790 new cases of breast cancer diagnosed in the United States so far this year, the U.S.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2023 Category: General Medicine Source Type: news
Elderly women at risk of breast cancer overdiagnosis
Elderly women who undergo routine screening mammography for breast cancer ar...Read more on AuntMinnie.comRelated Reading:
Women prefer mammography surveillance for low-risk DCIS
Can AI risk assessment improve screening mammography results?
Should elderly breast cancer survivors still get mammograms?
Most older breast cancer survivors still receive annual mammograms
Breast screening rates fall for older women in ACOs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2023 Category: Radiology Source Type: news
Women prefer mammography surveillance for low-risk DCIS
Active surveillance with mammography is the go-to choice for most women wit...Read more on AuntMinnie.comRelated Reading:
AI doesn't improve breast cancer screening in dense breasts
AI helps characterize breast microcalcifications
SBI: DCIS progression appears as new masses on surveillance imaging
Half of DCIS-treated women don't get ongoing imaging surveillance
Is palpable DCIS more aggressive than screen-detected? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2023 Category: Radiology Source Type: news
Former CEO pleads guilty to lying to feds during $40M health care fraud investigation
DCIS investigated the Broward-based company on allegations of health care fraud and payment of illegal kickbacks. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 27, 2023 Category: Pharmaceuticals Authors: Eman Elshahawy Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
DWI-MRI helps select suitable patients for ovarian cancer surgery
Diffusion-weighted MRI (DWI-MRI) helps in selecting ovarian cancer patient...Read more on AuntMinnie.comRelated Reading:
Abbreviated MRI protocols effective for emergency applications
Whole-body MRI is a viable option for lung cancer staging
Short MRI with DWI improves accuracy in diagnosing breast cancer
DWI-MRI helps breast cancer patients' chemotherapy response
DWI-MRI predicts whether women's DCIS will upstage after surgery (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 22, 2023 Category: Radiology Source Type: news
Antithrombotic therapy safe to continue during breast biopsy
Women can safely continue antithrombotic therapy during breast core-needle biopsy...Read more on AuntMinnie.comRelated Reading:
USPSTF calls for biennial mammography screening as of age 40
SBI: The presence of LCIS indicates increased breast cancer risk
Mammo-guided vacuum-assisted biopsy effective for thin breast tissue
SBI: DCIS progression appears as new masses on surveillance imaging
ACR releases updated breast cancer screening recommendation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2023 Category: Radiology Source Type: news
